Adipo Therapeutics completed a $1.9M seed funding bridge to advance the development of its lead asset ADPO-002 for the treatment of obesity through increased energy expenditure.
Amount Raised
$1.9 Million
Round Type
Seed
IndianapolisBiotechnologyHealth CareTherapeuticsBiopharmaInvestors
Description
Adipo Therapeutics, a late-stage, preclinical biopharmaceutical company focusing on treatments for obesity and Type 2 diabetes, has completed a $1.9 million seed funding bridge, bringing its total seed funding to $4 million. The funding will be used to complete critical studies to demonstrate ADPO-002's potential in converting energy-storing white adipose tissue to energy-burning brown adipose tissue in human fat. Key investors in Adipo include Purdue Research Foundation, Elevate Ventures, IU Ventures, and VisionTech Partners.
Quick answer
Adipo Therapeutics raised $1.9 Million in a Seed round, dated March 7, 2024. Investors: Vision Tech Partners, IU Ventures, Elevate Ventures and Purdue Research Foundation. Adipo Therapeutics is based in Indianapolis, Indiana, United States.
- How much did Adipo Therapeutics raise?
- Adipo Therapeutics raised $1.9 Million in a Seed round on March 7, 2024.
- Who invested in Adipo Therapeutics?
- Vision Tech Partners, IU Ventures, Elevate Ventures and Purdue Research Foundation are named as investors in this round.
- What does Adipo Therapeutics do?
- Adipo Therapeutics, an Indiana biotechnology company, is developing polymer-based, Notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue to induce browning, or white-to-beige adipocyte..
- Where is Adipo Therapeutics based and how big is it?
- Adipo Therapeutics is based in Indianapolis, Indiana, United States.
- Who are the decision-makers at Adipo Therapeutics?
- Fundz holds 1 contact at Adipo Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as Adipo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- BioLineRx Ltd raised $20M (Pre-Seed) on April 10, 2024.
- TORL BioTherapeutics raised $158M (Series B) on April 10, 2024.
- TORL BioTherapeutics raised $158M on April 4, 2024.
- AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
- Parabilis Medicines raised $145M (Series E) on March 1, 2024.
- Crinetics Pharmaceuticals raised $350M on March 1, 2024.
Who to call at Adipo Therapeutics, and when
A new round usually means Adipo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adipo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adipo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adipo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adipo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Adipo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.